Sinclair Sells Off Medical Derma Unit To Focus On Near-50%-Growth Aesthetics Biz
This article was originally published in Clinica
Sinclair IS Pharma plc is selling its medical dermatology assets to fellow UK company Alliance Pharma plc, in order to focus exclusively on its high-margin aesthetics business that is growing four times the market average.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.